INmune Bio, Inc.
TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS

Abstract:

A method of treating non-alcoholic steatohepatitis (NASH) in a subject includes administering to the subject a therapeutically effective amount of a selective inhibitor of solTNF-.alpha., whereby the subject is treated. In some embodiments, the selective inhibitor of solTNF-.alpha. includes a DN-TNF-.alpha. protein and/or a nucleic acid encoding the DN-TNF-.alpha. protein. In some embodiments, the DN-TNF-.alpha. protein includes XPRO1595.